Company Filing History:
3 out of 346 
1 out of 2 Years Active: 1982-1988
Title: The Innovations of Laszlo Rogdi
Introduction
Laszlo Rogdi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticonvulsive and sedative compounds. With a total of three patents to his name, Rogdi's work has the potential to impact the treatment of various neurological conditions.
Latest Patents
Rogdi's latest patents include novel anticonvulsive tetrahydro-1,2,4-oxadiazine-5-thion derivatives. These compounds are designed to provide effective anticonvulsive treatment with lower toxicity compared to existing medications like diphenyl hydantoine. Another significant patent involves tranquillo-sedative benzodiazepine derivatives, specifically a substituted 1,3,4,5-tetrahydro-2H-1,4-benzodiazepine-2-one. These innovations highlight Rogdi's commitment to improving patient outcomes through safer pharmaceutical options.
Career Highlights
Throughout his career, Laszlo Rogdi has worked with prominent companies such as Richter Gedeon Vegyeszeti Gyar Rt and MTA Központi Kémiai Kutató Intézete. His experience in these organizations has allowed him to refine his research skills and contribute to significant advancements in medicinal chemistry.
Collaborations
Rogdi has collaborated with esteemed colleagues, including Lajos Kisfaludy and Eva Palosi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Laszlo Rogdi's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his dedication to advancing medical science. His work continues to pave the way for safer and more effective treatments for patients.